WORCESTER, Mass., June 4, 2009 (GLOBE NEWSWIRE) -- Generex
Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader
in drug delivery for metabolic diseases...
Needle-Free Generex Oral-lyn(tm) Approved by Lebanese Ministry of Public Health for Diabetes Management Benta SAL Will Distribute Product
WORCESTER, Mass.,...
#12: Generex Biotechnology Receives Regulatory Approval to Initiate Phase III Clinical Trial for Generex Oral-lyn in First of the Global Locations Selected by the Company
The Company's
Medical and Marketing Teams Making Presentations to Leading Indian
Endocrinologists in Closed-Door Meetings in Mumbai, India
WORCESTER, Mass., Jan. 17, 2008 (PRIME NEWSWIRE)...
Generex Biotechnology "market outperform"Wednesday, January 16, 2008 9:22:33 AM ETRodman & RenshawNEW YORK, January 16 (newratings.com) - Analysts at Rodman & Renshaw reiterate...